Web9 apr. 2024 · Barclays dropped their target price on Ionis Pharmaceuticals from $44.00 to $40.00 and set an “equal weight” rating on the stock in a research report on Thursday, February 23rd. WebIonis Pharmaceuticals, Inc. Common Stock (IONS) Earnings Report Date Nasdaq Earnings: IONS Edit my quotes Ionis Pharmaceuticals, Inc. Common Stock (IONS) 0 …
Ionis reports third quarter financial results
Web13 apr. 2024 · Ionis Pharmaceuticals (NASDAQ:IONS – Get Rating) had its price target lifted by investment analysts at Morgan Stanley from $40.00 to $42.00 in a research report issued on Tuesday, Benzinga reports.The brokerage currently has an “equal weight” rating on the stock. Morgan Stanley’s price objective would suggest a potential upside of … Web22 feb. 2024 · As of December 31, 2024, Ionis had cash, cash equivalents and short-term investments of $2.0 billion compared to $2.1 billion at December 31, 2024. Ionis' year-end cash balance does not include... how do i delete apps from my ipad
Why Is Ionis Pharmaceuticals (IONS) Down 8.4% Since Last …
Web12 apr. 2024 · Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) issued its earnings results on Wednesday, February, 22nd. The company reported ($0.37) EPS for the quarter, topping … WebIonis Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 3.. CI. 02/22: Ionis Pharmaceuticals Swings to Q4 Loss as Revenue Falls: MT. 02/22: Ionis Pharmaceuticals : Q4 Earnings Snapshot: AQ. 02/22: Earnings Flash (IONS) IONIS PHARMACEUTICALS Posts Q4 Revenue $152M: MT. Web22 feb. 2024 · To access the Company's fourth quarter and full year 2024 earnings slides click here. About Ionis Pharmaceuticals, Inc. For more than 30 years, Ionis has been … how much is pirate shipping